|
ATRI
|
ATRION Corporation
|
US
|
NASDAQ
|
|
AUPH
|
Aurinia Pharmaceuticals Inc
|
US
|
NASDAQ
|
|
AVGR
|
Avinger, Inc.
|
US
|
NASDAQ
|
|
AVNS
|
Avanos Medical, Inc.
|
US
|
NYSE
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AVTX
|
Avalo Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AWH
|
Aspira Women's Health Inc.
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AYLA
|
Ayala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BAX
|
Baxter International Inc.
|
US
|
NYSE
|
|
BCEL
|
Atreca, Inc.
|
US
|
NASDAQ
|
|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
US
|
NASDAQ
|
|
BDX
|
Becton, Dickinson and Company
|
US
|
NYSE
|
|
BDXB
|
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
|
US
|
NYSE
|
|
BEAT
|
BioTelemetry, Inc.
|
US
|
NASDAQ
|
|
BFRI
|
Biofrontera Inc.
|
US
|
NASDAQ
|
|
BGXX
|
Bright Green Corporation
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
US
|
NASDAQ
|
|
BIOC
|
Biocept, Inc.
|
US
|
NASDAQ
|